Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib

BACKGROUND: Primary and secondary nonresponse to anti-tumor necrosis factor (TNF) therapy is common in patients with ulcerative colitis (UC), yet limited research has compared the effectiveness of subsequent biological therapy. OBJECTIVE: We sought to compare the effectiveness of vedolizumab and tof...

Descripción completa

Detalles Bibliográficos
Autores principales: Kappelman, Michael D, Long, Millie D, Zhang, Xian, Lin, Feng-Chang, Weisbein, Laura, Chen, Wenli, Burris, Jessica, Dorand, Jennifer E, Parlett, Lauren E, Fehlmann, Tara, Brensinger, Colleen M, Haynes, Kevin, Nair, Vinit, Kaul, Alan F, Dobes, Angela, Lewis, James D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284045/
https://www.ncbi.nlm.nih.gov/pubmed/37350775
http://dx.doi.org/10.1093/crocol/otad031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284045/
https://www.ncbi.nlm.nih.gov/pubmed/37350775
http://dx.doi.org/10.1093/crocol/otad031

Ejemplares similares